NasdaqCM - Nasdaq Real Time Price • USD
Akari Therapeutics, Plc (AKTX)
As of 1:52 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2021 | |||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | 0 |
| EPS Actual | -- | -- | -- | 0 |
| Difference | -- | -- | -- | 0 |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -1 | -1 | -4 | -3.4 |
| 30 Days Ago | -1 | -1 | -4 | -3.4 |
| 60 Days Ago | -1 | -1 | -4 | -3.4 |
| 90 Days Ago | -1 | -1 | -4 | -3.4 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AKTX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Related Tickers
PKBO Peak Bio, Inc.
0.0085
0.00%
XBIO Xenetic Biosciences, Inc.
3.8500
+1.85%
VRAX Virax Biolabs Group Limited
0.7000
+7.53%
XBIOW Xenetic Biosciences, Inc.
7.46
-17.11%
QUIA.ST QuiaPEG Pharmaceuticals Holding AB (publ)
0.0738
-1.99%
GLTO Galecto, Inc.
0.6705
-0.07%
ACHV Achieve Life Sciences, Inc.
4.5700
+0.66%
ANEB Anebulo Pharmaceuticals, Inc.
2.7600
+3.76%
KTTA Pasithea Therapeutics Corp.
7.24
+3.43%
CSBR Champions Oncology, Inc.
5.14
+1.15%